Join Cutco in supporting breast cancer research at Roswell Park Cancer Institute!
Cutco has generously committed to help fund a new research project at Roswell Park that will evaluate the potential of Tamoxifen in treating triple negative breast cancer. Tamoxifen has been widely used to treat other forms of breast cancer for decades. If successful for treating triple negative breast cancer, it can make an immediate, positive impact for patients.
To help fuel this study, you can purchase the limited-edition, Positively Pink Cutco Spatula Spreader and Super Shears, branded with the Roswell Park logo. Cutco will donate 10% of sales to this research study, with a goal of raising $50,000. The items are available for sale individually or in a two-piece gift set.
More About the Research
"Triple negative breast cancers, the most aggressive and difficult to treat form of breast cancer, represent about 15 percent of all breast cancer diagnoses in the U.S. and pose a great challenge in treatment. Therapies that are successful in other hormone-related cancers fail here, and while chemotherapy is effective in the beginning, it fails to stop progression. To meet the urgent need to identify new targets and develop new therapeutic studies for this disease, we propose repurposing the estrogen-blocking breast cancer drug tamoxifen to treat triple negative breast cancers with the intent to move on to clinical trials at a rapid pace."
- Gokul Das, PhD, Department of Pharmacology and Therapeutics